Purple Biotech Financial Overview
Purple Biotech's market cap is currently 22.30M. The company's EPS TTM is -0.5; its P/E ratio is -0.67; Purple Biotech is scheduled to report earnings on November 14, 2025, and the estimated EPS forecast is ―. See an overview of income statement, balance sheet, and cash flow financials.
